CIK 0001818844 · Non-accelerated filer<br>Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 854314201
- Phone
- 8666208655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-23 | Burch Richard Alan Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-06-23 | Keefer David R Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-06-23 | Thomas John C Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-06-23 | De La Rosa Abel Director | Grant or award · Stock Option (right to buy) | +5,250 | 5,250 | ||
| 2022-06-23 | Gendreau Roger Michael CHIEF MEDICAL OFFICER | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-23 | Grosswald Ralph SVP OF OPERATIONS | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-23 | Walsh Angela SVP OF FINANCE | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-23 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-05-23 | Walsh Angela SVP OF FINANCE | Purchase | +2,000 | $4.58 | $9K | 3,000 |
| 2022-05-23 | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | Purchase | +7,500 | $4.52 | $34K | 32,461 |
| 2022-05-18 | Whitley Richard James Director | Purchase | +500 | $4.53 | $2K | 2,500 |
| 2022-05-18 | Pridgen William Director | Purchase | +241 | $4.50 | $1K | 36,710 |
| 2022-05-17 | Pridgen William Director | Purchase | +13,450 | $4.38 | $59K | 36,469 |
| 2022-03-29 | Pridgen William Director | Purchase | +600 | $4.94 | $3K | 23,019 |
| 2022-03-23 | Pridgen William Director | Purchase | +2,197 | $5.46 | $12K | 22,419 |
| 2022-01-27 | Pridgen William Director | Purchase | +4,180 | $5.98 | $25K | 18,722 |
| 2022-01-07 | De La Rosa Abel Director | Purchase | +4,000 | $5.90 | $24K | 4,000 |
| 2022-01-06 | Whitley Richard James Director | Purchase | +1,800 | $5.72 | $10K | 2,000 |
| 2022-01-04 | Keefer David R Director | Purchase | +5,000 | $5.80 | $29K | 5,000 |
| 2022-01-04 | Thomas John C Director | Purchase | +1,000 | $5.65 | $6K | 1,000 |
Page 4 of 6 · 113 trades